Skip to main content
. 2022 Dec 31;13(1):73–84. doi: 10.34172/bi.2022.23523

Table 5. Measurement of foot paw diameter .

Groups Treatment and dose Paw diameter (mm) Percentage inhibition (%)
2nd day 6th day
I Normal control 1.57 ± 0.03 3.95 ± 0.02
II DSS control 1.42 ± 0.01 6.26 ± 0.01
III MFS-LD 1.45 ± 0.02* 2.20 ± 0.02** 45
IV MFS-HD 1.20 ± 0.01** 1.18 ± 0.02* 71
V Mesalazine 1.22 ± 0.01** 1.18 ± 0.02* 71

Values are mean ± SEM; n=6; ** P < 0.001 vs. Normal control; * P < 0.05 vs. DSS control.